Impaired thyroid hormone sensitivity increases the risk of papillary thyroid cancer and cervical lymph node metastasis

Abstract

Abstract Background: The association of thyroid hormone sensitivity with papillary thyroid carcinoma (PTC) isunclear. This study investigated the relationship between the thyroid hormone sensitivity indices and the risk of PTC and the influence of thyroid hormone sensitivity on the aggressive clinicopathologic features of PTC. Methods: This retrospective studyrecruited 1225 PTC patients and 369 patients with benign nodules undergoing surgery in Zhongshan Hospital in 2020. The thyroid hormone sensitivity indices were thyroid feedback quantile-based index (TFQI), TSH index (TSHI) and thyrotropin thyroxine resistance index (TT4RI). We employed logistic regression models to explore the correlation between the thyroid hormone sensitivity indices and the risk of PTC and its cervical lymph node metastasis (LNM). Results: PTC patients had significantly higher levels of TSH, TFQI, TSHI and TT4RI compared to the patients with benign nodules, but thyroid hormone levels did not differ significantly between the two groups. Logistic regression analysis revealed that the higher levels of TFQI, TSHI, and TT4RI were associated with an increased risk of PTC after adjustment for multiple risk factors (TFQI: OR=1.92, 95%CI: 1.39-2.65, P<0.001; TSHI: OR=2.33, 95%CI:1.67-3.26, P<0.001; TT4RI: OR=2.41, 95%CI:1.73-3.36, P<0.001). In addition, patients with decreased thyroid hormone sensitivity had a higher risk of cervical LNM in multiple logistic regression analysis (TFQI: OR=1.38, 95%CI:1.03-1.86, P=0.03; TSHI: OR=1.37, 95%CI:1.02-1.84, P=0.04; TT4RI: OR= 1.40, 95%CI:1.05-1.89, P=0.02). Conclusion: Impaired sensitivity to thyroid hormone was associated with an increased risk of PTC, and it is also associated with a higher risk of cervical LNM in PTC patients.